IAI Try AEM online
Home Help [Feedback] [For Subscribers] [Archive] [Search] --
IAI Accepts, published online ahead of print on 21 April 2008
This Article
Right arrow Full Text (PDF)
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Copyright Information
Right arrow Books from ASM Press
Right arrow MicrobeWorld
Google Scholar
Right arrow Articles by Bishop, J. L.
Right arrow Articles by Finlay, B. B.
PubMed
Right arrow PubMed Citation
Right arrow Articles by Bishop, J. L.
Right arrow Articles by Finlay, B. B.
Infect. Immun. doi:10.1128/IAI.01596-07
Copyright (c) 2008, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights Reserved.

The inositol phosphatase SHIP controls Salmonella Typhimurium infection in vivo

Jennifer L. Bishop, Laura M. Sly, Gerald Krystal, and B. Brett Finlay*

University of British Columbia, Michael Smith Laboratories, Room 301, 2185 East Mall, Vancouver, British Columbia, Canada, V6T 1Z4; The Terry Fox Laboratory, British Columbia Cancer Research Centre, 675 West 10th Avenue, Vancouver, British Columbia, Canada, V5Z 1L3

* To whom correspondence should be addressed. Email: bfinlay{at}interchange.ubc.ca.


   Abstract

The SH2 domain-containing inositol 5'-phosphatase, SHIP, negatively regulates various hematopoietic cell functions and is critical for maintaining immune homeostasis. However, whether SHIP plays a role in controlling bacterial infections in vivo remains unknown. Salmonella enterica causes human salmonellosis, a disease that ranges in severity from mild gastroenteritis to severe systemic illness, resulting in significant morbidity and mortality worldwide. Susceptibility of ship+/+ and ship-/- mice and bone marrow-derived macrophages to S. enterica serovar Typhimurium infection was compared. Ship-/- mice displayed an increased susceptibility to both oral and intraperitoneal S. Typhimurium infection and had significantly higher bacterial loads in intestinal and systemic sites than ship+/+ mice, indicating a role for SHIP in the gut associated and systemic pathogenesis of S. Typhimurium in vivo. Cytokine analysis of serum from orally infected mice showed that ship-/- mice produce lower levels of Th1 cytokines compared to ship+/+ animals at two days post-infection, and in vitro analysis of supernatants taken from infected bone marrow-derived macrophages derived to mimic the in vivo ship-/- alternatively activated (M2) macrophage phenotype correlated with this data. M2 macrophages were the predominant population in vivo in both oral and intraperitoneal infections, as tissue macrophages within the small intestine and peritoneal macrophages from ship-/- mice showed elevated levels of the M2 macrophage markers Ym1 and Arginase 1 compared to ship+/+ cells. Based on these data, we propose that M2 macrophage skewing in ship-/- mice contributes to ineffective clearance of Salmonella in vivo.







Home Help [Feedback] [For Subscribers] [Archive] [Search] --
J. Bacteriol. J. Virol. Eukaryot. Cell
Microbiol. Mol. Biol. Rev. Clin. Vaccine Immunol. All ASM Journals

Copyright © 2008 by the American Society for Microbiology. All rights reserved.